Complement factor H deficiency results in decreased neuroretinal expression of Cd59a in aged mice

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 10, 2012, Pages 6324-6330

  Faber, Carsten ^a   Williams, Jennifer ^a,b   Juel, Helene Bæk ^a   Greenwood, John ^b   Nissen, Mogens Holst ^a   Moss, Stephen E ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CLUSTERIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT FACTOR H; DECAY ACCELERATING FACTOR; MEMBRANE COFACTOR PROTEIN; RNA; TRANSCRIPTOME; VITRONECTIN; CD59 ANTIGEN; CD59A PROTEIN, MOUSE;

AGE; ANIMAL TISSUE; ARTICLE; CD59A GENE; CHOROID; CONTROLLED STUDY; GENE; GENE EXPRESSION; LIVER; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION; AGING; ANIMAL; C57BL MOUSE; DRUSEN; GENETICS; GENOTYPE; KIDNEY DISEASE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIGMENT EPITHELIUM; RETINA MACULA DEGENERATION;

AGING; ANIMALS; ANTIGENS, CD59; CHOROID; COMPLEMENT FACTOR H; GENOTYPE; KIDNEY DISEASES; MACULAR DEGENERATION; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RETINA; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; TRANSCRIPTOME;

EID: 84873250705     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10385     Document Type: Article

References (38)

1. la Cour M, Kiilgaard JF, Nissen MH. Age-related macular degeneration: epidemiology and optimal treatment. Drugs Aging. 2002;19:101-133.
2. Coleman HR, Chan CC, Ferris FL III, Chew EY. Age-related macular degeneration. Lancet. 2008;372:1835-1845.
3. Wang L, Clark ME, Crossman DK, et al. Abundant lipid and protein components of drusen. PLoS ONE. 2010;5:e10329.
4. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A. 2002;99:14682-14687.
5. Scholl HPN, Issa PC, Walier M, et al. Systemic complement activation in age-related macular degeneration. PLoS ONE. 2008;3:e2593.
6. Machalinska A, Dziedziejko V, Mozolewska-Piotrowska K, Karczewicz D, Wiszniewska B, Machalinski B. Elevated plasma levels of C3a complement compound in the exudative form of age-related macular degeneration. Ophthalmic Res. 2009;42: 54-59.
7. Sivaprasad S, Adewoyin T, Bailey TA, et al. Estimation of systemic complement C3 activity in age-related macular degeneration. Arch Ophthalmol. 2007;125:515-519.
8. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci. 2009; 50:5818-5827.
9. Anderson DH, Radeke MJ, Gallo NB, et al. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res. 2009; 29:95-112.
10. Xu H, Chen M, Forrester JV. Para-inflammation in the ageing retina. Prog Retin Eye Res. 2009;28:348-368.
11. Chen H, Liu B, Lukas TJ, Neufeld AH. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS ONE. 2008;3: e2339.
12. Chen M, Muckersie E, Robertson M, Forrester JV, Xu H. Upregulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp Eye Res. 2008;87:543-550.
13. Chen M, Muckersie E, Forrester JV, Xu H. Immune activation in retinal aging: a gene expression study. Invest Ophthalmol Vis Sci. 2010;51:5888-5896.
14. Luo C, Chen M, Xu H. Complement gene expression and regulation in mouse retina and retinal pigment epithelium/ choroid. Mol Vis. 2011;17:1588-1597.
15. Mattapallil MJ, Wawrousek EF, Chan CC, et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/ 6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci. 2012; 53:2921-2927.
16. Pickering MC, Cook HT, Warren J, et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet. 2002;31: 424-428.
17. Baalasubramanian S, Harris CL, Donev RM, et al. CD59a is the primary regulator of membrane attack complex assembly in the mouse. J Immunol. 2004;173:3684-3692.
18. Yang P, Tyrrell J, Han I, Jaffe GJ. Expression and modulation of RPE cell membrane complement regulatory proteins. Invest Ophthalmol Vis Sci. 2009;50:3473-3481.
19. Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ. Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci. 1993;34:3579-3584.
20. Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci. 2000;41:3492-3502.
21. Vogt SD, Barnum SR, Curcio CA, Read RW. Distribution of complement anaphylatoxin receptors and membrane-bound regulators in normal human retina. Exp Eye Res. 2006;83:834-840.
22. Coffey PJ, Gias C, McDermott CJ, et al. Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A. 2007;104:16651-16656.
23. Cashman SM, Ramo K, Kumar-Singh RA. Non membranetargeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration. PLoS ONE. 2011;6:e19078.
24. Bora NS, Kaliappan S, Jha P, et al. CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol. 2007;178:1783-1790.
25. Bora PS, Sohn JH, Cruz JMC, et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol. 2005;174:491-497.
26. Bora NS, Jha P, Lyzogubov VV, et al. Recombinant membranetargeted form of CD59 inhibits the growth of choroidal neovascular complex in mice. J Biol Chem. 2010;285:33826-33833.
27. Juel HB, Kaestel C, Folkersen LW, et al. Retinal pigment epithelial cells upregulate expression of complement factors after co-culture with activated T cells. Exp Eye Res. 2011;92: 180-188.
28. Thurman JM, Renner B, Kunchithapautham K, Holers VM, Rohrer B. Aseptic injury to epithelial cells alters cell surface complement regulation in a tissue specific fashion. Adv Exp Med Biol. 2010;664:151-158.
29. Thurman JM, Renner B, Kunchithapautham K, et al. Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury. J Biol Chem. 2009;284:16939-16947.
30. Li K, Fazekasova H, Wang N, et al. Expression of complement components, receptors and regulators by human dendritic cells. Mol Immunol. 2011;48:1121-1127.
31. Christmas SE, De La Mata Espinosa C, Halliday D, Buxton CA, Cummerson JA, Johnson PM. Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes. Immunology. 2006;119:522-528.
32. Luo C, Chen M, Madden A, Xu H. Expression of complement components and regulators by different subtypes of bone marrow-derived macrophages. Inflammation. 2012;35:1448-1461.
33. Martin BK. Transcriptional control of complement receptor gene expression. Immunol Res. 2007;39:146-159.
34. Mullins RF, Dewald AD, Streb LM, Wang K, Kuehn MH, Stone EM. Elevated membrane attack complex in human choroid with high risk complement factor H genotypes. Exp Eye Res. 2011;93:565-567.
35. Singh A, Faber C, Falk M, Nissen MH, Hviid TV, Sorensen TL. Altered expression of CD46 and CD59 on leukocytes in neovascular age-related macular degeneration. Am J Ophthalmol. 2012;154:193-199.
36. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers Drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and agerelated macular degeneration. Prog Retin Eye Res. 2001;20: 705-732.
37. Zhou J, Kim SR, Westlund BS, Sparrow JR. Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci. 2009;50:1392-1399.
38. Hollyfield JG, Perez VL, Salomon RG. A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol. 2010;41:290-298.